Research Paper Volume 13, Issue 14 pp 18701—18717
Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma
Figure 13. Results of CMap analysis.
Figure 13. Results of CMap analysis.